Why is blood pressure so hard to control in patients with type 2 diabetes? - Wikidata - awgldk - TriplyDB

Why is blood pressure so hard to control in patients with type 2 diabetes?

Why is blood pressure so hard to control in patients with type 2 diabetes?

http://www.wikidata.org/entity/Q36904456

about

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.Ambulatory blood pressure monitoring in diabetes and obesity-a review.Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups 2D-1H proton magnetic resonance spectroscopic imaging study on brain metabolite alterations in patients with diabetic hypertension The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes.

P2860

Q31043538-E96AFFA8-1101-4234-855E-5FE0C9594D3C Q34985607-9E5D5CC1-071B-4AD1-A037-BB6B3244C428 Q35024225-B6C41B5E-5000-461D-A972-1F1794D673C3 Q35387507-997696C9-C4AB-406C-8F24-F7848BE45B29 Q37980260-A3F02553-77B7-42B8-AF5F-E6C432BBCF5E Q38798156-A9143C1B-6634-4AC1-AC08-7C3E6A82F0BB Q42160141-06432916-3C12-41B3-BC9B-0F915AFE33C1 Q47709679-742548C9-4E1B-42A5-A87A-472A067142C7 Q50991760-30646392-6847-4993-BF6B-890BB2769BA8 Q51348976-B802A714-67A6-45FF-B68C-F2DA809F4E83

P2860

Why is blood pressure so hard to control in patients with type 2 diabetes?

http://www.wikidata.org/entity/Q36904456

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Why is blood pressure so hard to control in patients with type 2 diabetes?

@en

type

label

Why is blood pressure so hard to control in patients with type 2 diabetes?

@en

prefLabel

Why is blood pressure so hard to control in patients with type 2 diabetes?

@en

P1433

Q36904456-646AF008-003C-4E76-AEF6-64CBD44FC8DF

P1476

Q36904456-514BFA2B-089C-426E-B338-BB83940F9D5F

P2093

Q36904456-28B99AC2-8FD3-4AED-9EDA-EBDD85A1A30F

Q36904456-C67AD1AA-EC7B-4621-B91C-4345F0B2DE84

P2860

Q36904456-06E5F290-3F03-48C7-8190-63022AFA6782

Q36904456-09D263BC-44C8-44E3-9947-9E7C17A5AEB8

Q36904456-13650AB6-90BE-431F-8F3B-4AB067F5C06F

Q36904456-14FB5C65-C5FD-4012-8FA7-0D84D2571D2D

Q36904456-1BB6E06A-C057-4500-A02C-3A91F34F811B

Q36904456-209263AD-BF44-4604-B7ED-8E1A1B86D2BC

Q36904456-25A65050-08D9-4E5C-BF40-3F7E6697299F

Q36904456-26D32823-760A-48BD-B59A-3FB06E93CF34

Q36904456-2B2D4EDF-9E2B-410B-94EA-82954D5D2290

Q36904456-30A07702-4F86-4EA2-93FB-BC8F717E3160

P304

Q36904456-3B6E1DC7-583D-48A5-8337-79FBC14DB38E

P31

Q36904456-0360BE86-FE44-4F25-88EE-B461B03FBD2E

P356

Q36904456-9D6B54AF-8B26-41FD-9A28-689743E612F3

P433

Q36904456-D5BDCC4F-C09B-48DD-8E59-F7215ECE7D71

P478

Q36904456-002BEF4B-AFCA-46C9-A050-B4084CFF3411

P50

Q36904456-1306D921-58C9-45CA-A4E0-2305F8C3D41C

P577

Q36904456-40290A0A-12A9-4D39-90BD-9DB159F20061

P5875

Q36904456-00362117-3973-4EEB-A1CB-F5E1A96498CA

P698

Q36904456-3442507A-81B1-4CB3-AF26-D10ECB9620C9

P921

Q36904456-4D968A53-9728-4C33-8618-63E722B4689B

P356

J.1559-4564.2007.06124.X

P1433

Journal of the cardiometabolic syndrome

P1476

Why is blood pressure so hard to control in patients with type 2 diabetes?

@en

P2093

Kazuomi Kario

http://www.w3.org/2001/XMLSchema#string

Thomas G Pickering

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

P304

114-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1559-4564.2007.06124.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230234533

http://www.w3.org/2001/XMLSchema#string

P698

17684464

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes